The Nomination Committee's proposal for the Board of Directors and adjusted proposal for the Annual General Meeting 2020

In the notice of the Annual General Meeting of Brighter AB (publ) published on May 13, 2020, the Nomination Committee announced that it would get back with a proposal for the election of Board members. The Nomination Committee's proposal is presented below. The shareholder Recall Capital Nordic AB has also requested an adjustment of the proposed incentive program for the Board of Directors, which is described in full on Brighter's website https://brighter.se/.

The Nomination Committee's proposals
The Nomination Committee proposes that Truls Sjöstedt, Jan Stålemark, Emanuel Lipschütz and Tove Andersson is re-elected. Peter Sibirzeff and Anna Bernsten are proposed to be elected as new Directors of the Board. Truls Sjöstedt is proposed as Chairman of the Board.

Anna Bernsten
Anna Bernsten is a professional board director with more than 25 years of operational experience in international business development, strategy, management and branding in lifescience. Anna has previously worked with companies such as GE Healthcare and ASSA Abloy and has served on the Board of, among others, Oatly, Fagerhult, Nolato, Arcam, Björn Axén, Pågen, Medivir, Probi, Moberg Pharma and CellaVision.

Peter Sibirzeff
Peter Sibirzeff is a proven business leader with extensive international experience from the banking and finance industry, FinTech companies and HealthTech companies. Peter is currently Director of the American data visualization company 3Forge and has previously held leading roles in, among others, Orc Software, Alphacet and Jiway (Morgan Stanley/OMX joint venture).

Adjustment of the proposed incentive program for the Board of Directors
The shareholder Recall Capital Nordic AB (the "Shareholder") has proposed that the Annual General Meeting 2020 in Brighter AB (publ) ("Brighter") shall decide on an incentive program for the Board of Directors of Brighter ("the Board program"). According to the original proposal, a maximum of 995 181 so-called performance share rights could be allocated to participants in the program, and in total, the proposal meant that a maximum of 1,307,866 warrants could be issued to secure allotment and costs as a result of the program, corresponding to 0.66 percent of the number of shares and votes in Brighter.

The shareholder has requested that the proposal for the Board program should be amended so that the number of Performance Share Rights that can be allocated to the participants is increased to a maximum of 1,540,000 and that a maximum of 2,023,868 warrants can be issued to secure allotment and costs as a result of the program, which corresponds to 1.01 percent of the number of shares and votes in Brighter.

According to the Shareholder's amended proposal, a maximum of 440,000 of the warrants can be allocated to the Chairman of the Board (formerly 497,591) and a maximum of 220,000 of the warrants may be allocated to each ordinary Board member (formerly 99,518).

For further information, please contact:

Truls Sjöstedt, Executive Chairperson
+46 729 99 38 60 
truls.sjostedt@brighter.se

Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 10, adviser@eminova.se, www.eminova.se.

About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. 
The Company's shares are listed on Nasdaq First North Growth Market/BRIG.

About Us

Brighter is a Swedish health-tech company with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. https://brighter.se/ The Company's shares are listed on Nasdaq First North Growth Market/BRIG. Brighter’s Certified Adviser is Eminova Fondkommission AB +46 (0)8 – 684 211 10, adviser@eminova.se, www.eminova.se

Subscribe

Documents & Links